Avacta Therapeutics (AIM: AVCT, 'the Company', 'Avacta'), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, is pleased to announce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results